Correct choice is (c) If the biosensor is to be used for invasive monitoring in clinical situations, the probe must be tiny and biocompatible, having no toxic or antigenic effects
Explanation: If the biosensor is to be used for invasive monitoring in clinical situations, the probe must be tiny and biocompatible, having no toxic or antigenic effects. This property belongs to biosensor and hence may be improved or altered using genetic engineering. But the properties which can be altered are as follows:
• Enzymes from dangerous or unapproved microorganisms may be cloned into safe high-production microorganisms.
• Enzymes from slow growing or limited plant or animal tissue may be cloned into safe high-production microorganisms.
• Enzymes may be redesigned to fit more appropriately into industrial processes.